CCM
DVAX

CAAS Capital Management’s Dynavax Technologies DVAX Stock Holding History

CAAS Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-81,500
Closed -$803K – 998
2021
Q2 		$803K Buy
+81,500
New +$741K 0.01% 640

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CAAS Capital Management's DVAX Position: Q3 2021 in Review

CAAS Capital Management sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 81,500 shares — an estimated $803K sold.

CAAS Capital Management first reported a position in DVAX in Q2 2021 and held it in 1 quarter. The position peaked at $803K in Q2 2021. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

  • CAAS Capital Management reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 81,500 Dynavax Technologies shares in Q3 2021, an estimated $803K.
  • CAAS Capital Management first reported a position in Dynavax Technologies in Q2 2021 and held it in 1 quarter.
  • CAAS Capital Management's Dynavax Technologies position peaked at $803K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.